Truist Financial Corp Concert Pharmaceuticals, Inc. Transaction History

Truist Financial Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 22, 2022	SELL	$2.73 - $3.94 $54,600 - $78,800	-20,000 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$4.86 - $13.07 $63,180 - $169,910	-13,000 Reduced 39.39%	20,000 $100,000
Q4 2020 Nov 19, 2021	SELL	$9.48 - $12.84 $22,752 - $30,816	-2,400 Reduced 6.78%	33,000 $417,000
Q4 2020 Feb 18, 2021	SELL	$9.48 - $12.84 $3,223 - $4,365	-340 Reduced 0.95%	35,400 $447,000
Q1 2020 May 15, 2020	BUY	$5.98 - $13.09 $59,800 - $130,900	10,000 Added 38.85%	35,740 $316,000
Q4 2019 Feb 14, 2020	BUY	$5.71 - $9.22 $146,975 - $237,322	25,740 New	25,740 $237,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Truist Financial Corp with notifications on news.